BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36423303)

  • 21. Modular electron transfer circuits for synthetic biology: insulation of an engineered biohydrogen pathway.
    Agapakis CM; Silver PA
    Bioeng Bugs; 2010; 1(6):413-8. PubMed ID: 21468209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innovative Approaches of Engineering Tumor-Targeting Bacteria with Different Therapeutic Payloads to Fight Cancer: A Smart Strategy of Disease Management.
    Allemailem KS
    Int J Nanomedicine; 2021; 16():8159-8184. PubMed ID: 34938075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer.
    Nguyen VH; Kim HS; Ha JM; Hong Y; Choy HE; Min JJ
    Cancer Res; 2010 Jan; 70(1):18-23. PubMed ID: 20028866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain.
    Yu B; Yang M; Shi L; Yao Y; Jiang Q; Li X; Tang LH; Zheng BJ; Yuen KY; Smith DK; Song E; Huang JD
    Sci Rep; 2012; 2():436. PubMed ID: 22666539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Salmonella strains as cancer therapy agents and testing in tumor cell lines.
    Eisenstark A; Kazmierczak RA; Dino A; Khreis R; Newman D; Schatten H
    Methods Mol Biol; 2007; 394():323-54. PubMed ID: 18363243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current advances in bacteria-based cancer immunotherapy.
    Guo C; Liu J; Zhang Y
    Eur J Immunol; 2024 Feb; 54(2):e2350778. PubMed ID: 38105295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ biomolecule production by bacteria; a synthetic biology approach to medicine.
    Flores Bueso Y; Lehouritis P; Tangney M
    J Control Release; 2018 Apr; 275():217-228. PubMed ID: 29477351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of synthetic gene circuits in the Escherichia coli genome.
    Ying BW; Akeno Y; Yomo T
    Methods Mol Biol; 2013; 1073():157-68. PubMed ID: 23996446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-seeking Salmonella amino acid auxotrophs.
    Hoffman RM
    Curr Opin Biotechnol; 2011 Dec; 22(6):917-23. PubMed ID: 21498066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New technologies in developing recombinant-attenuated bacteria for cancer therapy.
    Liang K; Liu Q; Kong Q
    Biotechnol Bioeng; 2021 Feb; 118(2):513-530. PubMed ID: 33038015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of genome engineering in medical synthetic biology].
    Wang F; Zhao D; Qi LS
    Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):422-435. PubMed ID: 28941341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic Bacteria for Therapeutics.
    Vo P; Lee HM; Na D
    J Microbiol Biotechnol; 2019 Jun; 29(6):845-855. PubMed ID: 31216840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic biology for plant genetic engineering and molecular farming.
    Wang Y; Demirer GS
    Trends Biotechnol; 2023 Sep; 41(9):1182-1198. PubMed ID: 37012119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteria-cancer interactions: bacteria-based cancer therapy.
    Duong MT; Qin Y; You SH; Min JJ
    Exp Mol Med; 2019 Dec; 51(12):1-15. PubMed ID: 31827064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering bacteria for biogenic synthesis of chalcogenide nanomaterials.
    Chellamuthu P; Tran F; Silva KPT; Chavez MS; El-Naggar MY; Boedicker JQ
    Microb Biotechnol; 2019 Jan; 12(1):161-172. PubMed ID: 30369058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic spatial patterning in bacteria: advances based on novel diffusible signals.
    Oliver Huidobro M; Tica J; Wachter GKA; Isalan M
    Microb Biotechnol; 2022 Jun; 15(6):1685-1694. PubMed ID: 34843638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering Diagnostic and Therapeutic Gut Bacteria.
    Landry BP; Tabor JJ
    Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered cell-based therapies: a vanguard of design-driven medicine.
    Dudek RM; Chuang Y; Leonard JN
    Adv Exp Med Biol; 2014; 844():369-91. PubMed ID: 25480651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Temporal Proteome Profiling Reveals the Immunological Triple Offensive Induced by Synthetic Anti-Cancer
    Yang S; Zhao W; Zhu M; Hu H; Wang W; Zang Z; Jin M; Bi J; Huang J; Liu C; Li X; Yin P; Li N
    Front Immunol; 2021; 12():712936. PubMed ID: 34489962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rock-paper-scissors: Engineered population dynamics increase genetic stability.
    Liao MJ; Din MO; Tsimring L; Hasty J
    Science; 2019 Sep; 365(6457):1045-1049. PubMed ID: 31488693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.